Interleukin-17 in inflammatory myopathies (Q37986587)

26 August 2017

title

Interleukin-17 in inflammatory myopathies (English)

1 reference

26 August 2017

0 references

0 references

2

Pierre Miossec

0 references

author name string

Anne Tournadre

series ordinal

1

1 reference

26 August 2017

publication date

1 June 2012

1 reference

Current Rheumatology Reports

26 August 2017

published in

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

252-256

1 reference

Interleukin-17 and type 17 helper T cells

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

Cytokine response in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

Effect of tumor necrosis factor-alpha on skeletal muscle metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

IL-17 inhibits human Th1 differentiation through IL-12R beta 2 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11926-012-0242-X

The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model

21 January 2018

1 reference

12 December 2020

Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines.

1 reference

12 December 2020

Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis.

1 reference

12 December 2020

Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation

1 reference

12 December 2020

Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells

1 reference

12 December 2020

Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction

1 reference

12 December 2020

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies

1 reference

12 December 2020

IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood

1 reference

12 December 2020

10.1007/S11926-012-0242-X

Identifiers

DOI

1 reference

26 August 2017

1 reference